Skin Squamous Cell Carcinoma — Trials

Skin Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

211 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 89
Recruiting: 47
Ph III recruiting: 4
Growth YoY: —
Industry share: 22%
Top sponsor: National Cancer Institute (NCI)
Termination share: 53.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (39)

clinicaltrialsPublishedShowing 1–18 of 18 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03574792	Gabapentin, Methadone, and Oxycodone With or Without Venlafaxine Hydrochloride in Managing Pain in Participants With Stage II-IV Squamous Cell Head and Neck Cancer Undergoing Chemoradiation Therapy	completed	Phase 2	62	Roswell Park Cancer InstituteOTHER	1	Apr 16, 2026	clinicaltrials
NCT06036836	Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)	completed	Phase 2	163	Merck Sharp & Dohme LLCINDUSTRY	10	Mar 19, 2026